Masahito Ebina

17.2k total citations · 2 hit papers
97 papers, 7.2k citations indexed

About

Masahito Ebina is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Masahito Ebina has authored 97 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Pulmonary and Respiratory Medicine, 18 papers in Surgery and 16 papers in Molecular Biology. Recurrent topics in Masahito Ebina's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (38 papers), Medical Imaging and Pathology Studies (14 papers) and Neonatal Respiratory Health Research (13 papers). Masahito Ebina is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (38 papers), Medical Imaging and Pathology Studies (14 papers) and Neonatal Respiratory Health Research (13 papers). Masahito Ebina collaborates with scholars based in Japan, United States and Canada. Masahito Ebina's co-authors include Toshihiro Nukiwa, S. Yamada, Kyoko Shinya, Yoshihiro Kawaoka, Noriyuki Kasai, Masakichi Motomiya, Tohru Takahashi, Yuichiro Kimura, Tamotsu Takishima and Takashi Aikawa and has published in prestigious journals such as Nature, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Masahito Ebina

93 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Influenza virus receptors in the human airway

2006 1.1k citations Masahito Ebina et al. profile →
Pirfenidone in idiopathic pulmonary fibrosis

2009 686 citations Masahito Ebina, Yasuhiro Kondoh et al. European Respiratory Journal profile →

Peers

Countries citing papers authored by Masahito Ebina

Since Specialization

Citations

This map shows the geographic impact of Masahito Ebina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahito Ebina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahito Ebina more than expected).

Fields of papers citing papers by Masahito Ebina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahito Ebina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahito Ebina. The network helps show where Masahito Ebina may publish in the future.

Co-authorship network of co-authors of Masahito Ebina

This figure shows the co-authorship network connecting the top 25 collaborators of Masahito Ebina. A scholar is included among the top collaborators of Masahito Ebina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahito Ebina. Masahito Ebina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sequential Granulocyte-Macrophage Colony-Stimulating Factor Inhalation after Whole-Lung Lavage for Pulmonary Alveolar Proteinosis. A Report of Five Intractable Cases 2017 ·Annals of the American Thoracic Society ·Shinya Ohkouchi, Keiichi Akasaka, Toshio Ichiwata, Shu Hisata, Hideya Iijima, Toshinori Takada, Hiroki Tsukada, Hideaki Nakayama, (unknown), Toshiya Irokawa, Hiromasa Ogawa, Yoko Shibata, Masakazu Ichinose, Masahito Ebina, Toshihiro Nukiwa, Hájíme Kurosawa, Koh Nakata, Ryushi Tazawa	22
2	NRF2 Intensifies Host Defense Systems to Prevent Lung Carcinogenesis, but After Tumor Initiation Accelerates Malignant Cell Growth 2016 ·Cancer Research ·Hironori Satoh, Takashi Moriguchi, Daisuke Saigusa, Liam Baird, Lei Yu, Hirofumi Rokutan, (unknown), Masahito Ebina, Tatsuhiro Shibata, Masayuki Yamamoto	85
3	Pathognomonic remodeling of blood and lymphatic capillaries in idiopathic pulmonary fibrosis 2016 ·Respiratory Investigation ·Masahito Ebina	17
4	Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases 2014 ·Journal of Thoracic and Cardiovascular Surgery ·Toshihiko Satō, Atsushi Watanabe, Haruhiko Kondo, Masato Kanzaki, Kenichi Okubo, Kohei Yokoi, Kunio Matsumoto, Takashi Marutsuka, Hirohiko Shinohara, Satoshi Teramukai, Kazuma Kishi, Masahito Ebina, Yukihiko Sugiyama, (unknown), Hiroshi Date	107
5	Nrf2 Prevents Initiation but Accelerates Progression through the Kras Signaling Pathway during Lung Carcinogenesis 2013 ·Cancer Research ·Hironori Satoh, Takashi Moriguchi, Jun Takai, Masahito Ebina, Masayuki Yamamoto	203
6	Secretory leukocyte protease inhibitor modulates urethane-induced lung carcinogenesis 2013 ·Carcinogenesis ·(unknown), Tatsuro Fukuhara, Takuji Suzuki, Akira Nakamura, Jamal Zaini, Toshiaki Kikuchi, Masahito Ebina, T. Nukiwa	14
7	Carcinoembryonic antigen-related cell adhesion molecules as surrogate markers for EGFR inhibitor sensitivity in human lung adenocarcinoma 2012 ·British Journal of Cancer ·Masayuki Kobayashi, Yasuhiro Miki, Masahito Ebina, Keiko Abe, Kazushige Mori, (unknown), Takashi Suzuki, (unknown), Makoto Maemondo, (unknown), Akira Inoue, Hiroyuki Kumamoto, Takashi Kondo, H. Yamada-Okabe, T. Nukiwa, Hironobu Sasano	24
8	Toll-Like Receptor 4 Potentiates Ca2+-Dependent Secretion of Electrolytes from Swine Tracheal Glands 2011 ·American Journal of Respiratory Cell and Molecular Biology ·Koji Murakami, Tsutomu Tamada, Masayuki Nara, (unknown), Toshiaki Kikuchi, Masahiko Kanehira, Yoshio Maruyama, Masahito Ebina, Toshihiro Nukiwa	10
9	Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment 2011 ·Respiratory Research ·Arata Azuma, Yoshio Taguchi, Takashi Ogura, Masahito Ebina, Hiroyuki Taniguchi, Yasuhiro Kondoh, Moritaka Suga, Hiroki Takahashi, Koichiro Nakata, Atsuhiko Sato, Shoji Kudoh, Toshihiro Nukiwa	88
10	Acute eosinophilic pneumonia associated with the inhalation of phosgene gas under the presence of cigarette smoking 2010 ·Respiratory Medicine CME ·Tsutomu Tamada, Masayuki Nara, Koji Murakami, (unknown), Masahito Ebina, Toshihiro Nukiwa	1
11	Pirfenidone in idiopathic pulmonary fibrosis breakdown → 2009 ·European Respiratory Journal ·(unknown), Masahito Ebina, Yasuhiro Kondoh, (unknown), Arata Azuma, Motomu Suga, (unknown), Hiroki Takahashi, Kohei Nakata, Akitoshi Sato, (unknown), Ganesh Raghu, (unknown), T. Nukiwa	686
12	Contribution of High-Mobility Group Box-1 to the Development of Ventilator-induced Lung Injury 2006 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Akitoshi Ishizaka, Sadatomo Tasaka, Hidefumi Koh, Hiroshi Ueno, Fumimasa Amaya, Masahito Ebina, Shingo Yamada, (unknown), (unknown), Kiyoshi Moriyama, Toru Kotani, Satoru Hashimoto, Hiroshi Morisaki, Edward Abraham, Junzo Takeda	125
13	Granulocyte-Macrophage Colony–Stimulating Factor and Lung Immunity in Pulmonary Alveolar Proteinosis 2005 ·American Journal of Respiratory and Critical Care Medicine ·Ryushi Tazawa, Emi Hamano, Toru Arai, Hiromitsu Ohta, Osamu Ishimoto, Kanji Uchida, Masato Watanabe, Junichi Saito, (unknown), Yasuhiko Hirabayashi, Ikuo Ishige, Yoshinobu Eishi, Koichi Hagiwara, Masahito Ebina, Yoshikazu Inoue, Koh Nakata, Toshihiro Nukiwa	77
14	Heterogeneous Increase in CD34-positive Alveolar Capillaries in Idiopathic Pulmonary Fibrosis 2004 ·American Journal of Respiratory and Critical Care Medicine ·Masahito Ebina, Minoru Shimizukawa, Naoko Shibata, Yuichiro Kimura, Takashi Suzuki, Mareyuki Endo, Hironobu Sasano, Takashi Kondo, Toshihiro Nukiwa	230
15	Interstitial lung disease associated with drug therapy 2004 ·British Journal of Cancer ·P. Camus, Shoji Kudoh, Masahito Ebina	131
16	High Level of Vascular Endothelial Growth Factor in Hemorrhagic Pleural Effusion of Cancer 2002 ·Oncology ·Osamu Ishimoto, Yasuo Saijo, (unknown), Yuichiro Kimura, Masahito Ebina, (unknown), (unknown), Yushi Nakai, Toshihiro Nukiwa	40
17	Towards an Effective Gene Therapy for Idiopathic Pulmonary Fibrosis 2002 ·CHEST Journal ·Masahito Ebina, Minoru Shimizukawa, (unknown), Makoto Miki, Daizo Koinuma, Mika Watanabe, Hiroshi Munakata, T. Nukiwa	8
18	Papillary serous carcinoma of the peritoneum: analysis of clonality of peritoneal tumors 2000 ·Journal of Gastroenterology ·(unknown), (unknown), (unknown), (unknown), Hisao Ueyama, Masahito Ebina, (unknown), Tadao Bamba	9
19	Analysis of Ki-ras, p53, and MDM2 Genes in Uterine Leiomyomas and Leiomyosarcomas 1997 ·Gynecologic Oncology ·Kevin L. Hall, Michael Teneriello, Robert R. Taylor, Stephen J. Lemon, Masahito Ebina, R. Ilona Linnoila, (unknown), Robert C. Park, Michael J. Birrer	62
20	Non-radioactive localization of nucleic acids by direct in situ PCR and in situ RT-PCR in paraffin-embedded sections. 1995 ·Journal of Histochemistry & Cytochemistry ·Alfredo Martı́nez, Mark Miller, Katie Quinn, Edward J. Unsworth, Masahito Ebina, Frank Cuttitta	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact